Encompass Health Corporation
Bear Case (25th pct.)
-42.6% vs price
Base Case (Median)
0.7% vs price
Bull Case (75th pct.)
13.3% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $17.90 | -85.3% | High (40%) |
| PE Comparable | $136.64 | 12.0% | Medium (25%) |
| Growth Trajectory DCF | $217.05 | 77.9% | Medium (20%) |
| Graham Number | $57.89 | -52.5% | Medium (40%) |
| EV/EBITDA | $139.71 | 14.5% | Medium (20%) |
| EV/FCF | $82.27 | -32.6% | Medium (20%) |
| Earnings Power Value | $122.80 | 0.7% | Medium (50%) |
Based on 7 out of 8 methods, EHC appears fairly valued at the current price of $121.99. The base case fair value of $122.80 implies 0.7% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.